Related Experiment Video
Updated: Jun 3, 2026

07:55
Ex Vivo Organotypic Corneal Model of Acute Epithelial Herpes Simplex Virus Type I Infection
Published on: November 3, 2012
["Herpetic keratitis". Various expressions require different therapeutic approaches]
1Klinik für Augenheilkunde und Hochschulambulanz, Universitätsklinikum des Saarlandes UKS, Kirrbergerstr. 1, 66424, Homburg/Saar, Deutschland. berthold.seitz@uks.eu
Summary
Herpetic keratitis, caused by herpes simplex virus (HSV), presents varied clinical forms. Early recognition and tailored treatment, including antiviral therapy, significantly improve outcomes, even post-keratoplasty.
Area of Science:
- Ophthalmology
- Virology
- Infectious Diseases
Context:
- Herpes simplex virus (HSV) is a primary cause of infectious keratitis.
- Herpetic keratitis exhibits diverse clinical presentations, often termed a 'chameleon'.
- Effective management relies on recognizing these varied clinical forms.
Purpose:
- To outline the different clinical manifestations of herpetic keratitis.
- To emphasize the importance of tailored treatment strategies for each clinical type.
- To highlight current therapeutic approaches for managing HSV keratitis.
Summary:
- Herpetic keratitis presents as epithelial (dendritic/geographic), stromal (necrotizing/non-necrotizing), endotheliitis (disciform), neurotrophic keratopathy, and corneal scars.
- Ocular hypertension requires non-surgical management, avoiding prostaglandin analogues.
- Topical artificial tears and acyclovir ointment during quiescent periods help prevent recurrences.
- Systemic acyclovir (2x400mg/day) for at least one year is crucial after keratoplasty or for severe recurrences.
Impact:
- Knowledge of clinical variations enables ophthalmologists to adjust treatment effectively.
- Adequate management strategies have reduced the severity and 'terror' associated with HSV keratitis.
- Improved outcomes are achievable even in complex cases, including post-keratoplasty scenarios.
Related Concept Videos
Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

